Gefimipsa

Gefimipsa is a commercial drug that is prescribed in the form of Tablet, Capsule. It is primarily used for the treatment of Non-Small Cell Lung Cancer. Secondary and off-label uses of Gefimipsa have also been mentioned below.

The right dosage of Gefimipsa depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.

Gefimipsa also has some side effects, the most common being Weakness, Dry Skin, Dark colored (brown) urine. Some other side effects of Gefimipsa have been listed ahead. Such side effects of Gefimipsa normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.

It is also important to note that Gefimipsa has a Severe effect for pregnant women and Severe effect on lactating mothers. Further, the section on Gefimipsa related warnings talks about Gefimipsa's effects on the liver, heart and kidney.

Individuals suffering from medical conditions like Liver Disease, Gastritis must refrain from the use of Gefimipsa since this can cause severe adverse effects. Other contraindications of Gefimipsa have been discussed in the sections ahead.

Drug reaction of Gefimipsa with other medicines has been reported. See below for a complete list.

Along with the above-mentioned precautions, remember that taking Gefimipsa is considered not safe while driving, and is not addictive.